Inventor
SHUICHAN XU
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds28%
C07KPeptides6%
PatentTitleYear
12,404,241Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith202511,873,283Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith202411,590,139Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith202311,331,380Cereblon-based heterodimerizable chimeric antigen receptors202211,325,889Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith202211,149,007Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to CELGENE CORP (5)· patent assignee history
2021–2025Based in US· patent location history
2023Patents assigned to SIGNAL PHARM LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE CORP | 5 | 2021–2025 |
| SIGNAL PHARM LLC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2025 |